Table 1.

PROTAC degraders in clinical trials for prostate cancer [3].

Name of the PROTAC	Clinical Trial No.	Date of Entry into Clinical Trials	Highest Clinical Phase	Target Protein	E3 Ligase Used
ARV-110	NCT03888612	March, 2019	Phase II	AR	Cereblon
CC-94676	NCT04428788	June, 2020	Phase I	AR	_
ARV-766	NCT05067140	October, 2021	Phase I	AR	Cereblon